Pangaea Oncology, S.A. (PANG.MC)

EUR 1.7

(1.19%)

Long Term Debt Summary of Pangaea Oncology, S.A.

Pangaea Oncology, S.A.'s latest annual long term debt in 2023 was 1.86 Million EUR , down -18.43% from previous year.
Pangaea Oncology, S.A.'s latest quarterly long term debt in 2023 FY was 1.86 Million EUR , down -18.43% from previous quarter.
Pangaea Oncology, S.A. reported annual long term debt of 2.28 Million EUR in 2022, down -30.05% from previous year.
Pangaea Oncology, S.A. reported annual long term debt of 3.26 Million EUR in 2021, down -14.04% from previous year.
Pangaea Oncology, S.A. reported quarterly long term debt of 947.38 Thousand EUR for 2023 Q1, down -58.54% from previous quarter.
Pangaea Oncology, S.A. reported quarterly long term debt of 1.63 Million EUR for 2023 Q2, up 72.52% from previous quarter.

Annual Long Term Debt Chart of Pangaea Oncology, S.A. (2023 - 2013)

Historical Annual Long Term Debt of Pangaea Oncology, S.A. (2023 - 2013)

Year	Long Term Debt	Long Term Debt Growth
2023	1.86 Million EUR	-18.43%
2022	2.28 Million EUR	-30.05%
2021	3.26 Million EUR	-14.04%
2020	3.79 Million EUR	345.06%
2019	853.77 Thousand EUR	-59.77%
2018	2.12 Million EUR	-75.37%
2017	8.61 Million EUR	292.73%
2016	2.19 Million EUR	-13.34%
2015	2.53 Million EUR	442.05%
2014	466.92 Thousand EUR	-9.38%
2013	515.27 Thousand EUR	0.0%

Year	Long Term Debt	Long Term Debt Growth
2023 FY	1.86 Million EUR	-18.43%
2023 Q1	947.38 Thousand EUR	-58.54%
2023 Q2	1.63 Million EUR	72.52%
2023 Q4	1.86 Million EUR	172.74%
2023 Q3	683.31 Thousand EUR	-58.19%
2022 Q4	2.28 Million EUR	0.0%
2022 FY	2.28 Million EUR	-30.05%
2022 Q2	2.78 Million EUR	0.0%
2021 FY	3.26 Million EUR	-14.04%
2021 Q4	3.26 Million EUR	0.0%
2021 Q2	3.41 Million EUR	0.0%
2020 Q2	1.84 Million EUR	0.0%
2020 FY	3.79 Million EUR	345.06%
2020 Q4	3.79 Million EUR	0.0%
2019 Q4	853.77 Thousand EUR	0.0%
2019 FY	853.77 Thousand EUR	-59.77%
2019 Q2	1.77 Million EUR	0.0%
2018 Q4	2.12 Million EUR	0.0%
2018 Q2	7.01 Million EUR	0.0%
2018 FY	2.12 Million EUR	-75.37%
2017 FY	8.61 Million EUR	292.73%
2017 Q4	8.61 Million EUR	0.0%
2017 Q2	2.32 Million EUR	0.0%
2016 Q2	3.12 Million EUR	0.0%
2016 FY	2.19 Million EUR	-13.34%
2016 Q4	2.19 Million EUR	0.0%
2015 Q4	2.53 Million EUR	0.0%
2015 FY	2.53 Million EUR	442.05%
2014 FY	466.92 Thousand EUR	-9.38%
2013 FY	515.27 Thousand EUR	0.0%

Peer Long Term Debt Comparison of Pangaea Oncology, S.A.

Name	Long Term Debt	Long Term Debt Difference
Clínica Baviera, S.A.	503.02 Thousand EUR	-270.499%